Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 42 |
| Diagnostic | 5 |
| Basic Science | 4 |
| Health Services Research | 2 |
| Supportive Care | 2 |
| Other | 1 |
| Screening | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 114 |
| interventional | 57 |
| Observational | 49 |
| Registry | 8 |
```
| intervention_type | Study_Count |
|---|---|
| Drug|placebo | 14 |
| Drug | 12 |
| Device | 10 |
| Procedure | 9 |
| Other | 4 |
| Behavioral | 3 |
| Diagnostic Test | 2 |
| Behavioral|Drug | 1 |
| Drug|Other|placebo | 1 |
| Drug|Procedure | 1 |
| Country | Study_Count |
|---|---|
| United States | 23 |
| Denmark | 4 |
| France | 4 |
| Russian Federation | 3 |
| United Kingdom | 3 |
| United States|Canada | 3 |
| Canada | 2 |
| Poland | 2 |
| Spain | 2 |
| United States|Belgium|Czechia|Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom | 2 |
| Brazil | 1 |
| China | 1 |
| Czechia | 1 |
| Germany | 1 |
| Germany|Italy|Serbia|United Kingdom | 1 |
| Italy | 1 |
| United States|Germany|Korea, Republic of|Spain | 1 |
| United States|Korea, Republic of|Poland | 1 |
| United States|Spain | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 40 |
| 2 | 2 |
| 3 | 2 |
| 4 | 1 |
| 5 | 1 |
| 6 | 1 |
| 7 | 3 |
| 11 | 1 |
| 15 | 1 |
| 32 | 1 |
| 47 | 1 |
| 52 | 1 |
| 64 | 1 |
| 72 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 23 |
| Phase 2 | 20 |
| Phase 1 | 5 |
| Phase 3 | 4 |
| Phase 4 | 3 |
| Phase 2/Phase 3 | 2 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 13 |
| 2 | 28 |
| 3 | 5 |
| 4 | 1 |
| 6 | 1 |
| 8 | 1 |
| NA | 8 |
| Measure | N.A | Phase.1 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|
| Min. | 10.0000 | 15 | 12.0 | 39.00 | 20.00 | 14.00000 |
| 1st Qu. | 25.5000 | 24 | 30.5 | 106.75 | 21.50 | 22.50000 |
| Median | 72.0000 | 42 | 47.0 | 174.50 | 56.00 | 31.00000 |
| Mean | 100.6087 | 59 | 74.0 | 174.50 | 95.75 | 31.66667 |
| 3rd Qu. | 128.0000 | 100 | 72.5 | 242.25 | 130.25 | 40.50000 |
| Max. | 500.0000 | 114 | 249.0 | 310.00 | 251.00 | 50.00000 |
| group_type | Group_Count |
|---|---|
| Experimental | 46 |
| Active Comparator | 20 |
| Placebo Comparator | 18 |
| Other | 10 |
| NA | 8 |
| No Intervention | 6 |
| Sham Comparator | 2 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 28 |
| Single Group Assignment | 13 |
| Crossover Assignment | 7 |
| NA | 7 |
| Sequential Assignment | 2 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 42 |
| Diagnostic | 5 |
| Basic Science | 4 |
| Health Services Research | 2 |
| Supportive Care | 2 |
| Other | 1 |
| Screening | 1 |
| Country | Study_Count |
|---|---|
| United States | 26 |
| China | 5 |
| France | 4 |
| Germany | 3 |
| NA | 2 |
| Singapore | 2 |
| United States|Canada | 2 |
| Belgium | 1 |
| Canada | 1 |
| Greece | 1 |
| Netherlands | 1 |
| Poland | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 43 |
| 2 | 1 |
| 3 | 1 |
| 5 | 1 |
| 9 | 1 |
| 12 | 1 |
| 13 | 1 |
| Measure | Observational |
|---|---|
| Min | 20.0000 |
| 1st Qu | 110.0000 |
| Median | 200.0000 |
| Mean | 857.1915 |
| 3rd Qu | 572.0000 |
| Max | 9999.0000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 26 |
| NA | 14 |
| Case-Control | 5 |
| Case-Only | 2 |
| Family-Based | 2 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 30 |
| NA | 12 |
| Retrospective | 4 |
| Cross-Sectional | 2 |
| Other | 1 |
| Country | Study_Count |
|---|---|
| United States | 2 |
| Canada | 1 |
| Italy | 1 |
| Korea, Republic of | 1 |
| Sweden | 1 |
| United States|Australia|Canada|New Zealand|United Kingdom | 1 |
| United States|Canada|Germany|Italy|Netherlands|United Kingdom | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 6 |
| 36 | 1 |
| 44 | 1 |
| Measure | Registries |
|---|---|
| Min | 99.00 |
| 1st Qu | 250.00 |
| Median | 1575.00 |
| Mean | 2618.50 |
| 3rd Qu | 3324.75 |
| Max | 10000.00 |
| observational_model | Study_Count |
|---|---|
| Case-Only | 3 |
| Cohort | 3 |
| Family-Based | 2 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 8 |
| target_duration | Study_Count |
|---|---|
| 5 Years | 3 |
| 2 Years | 2 |
| 1 Day | 1 |
| 10 Years | 1 |
| 3 Years | 1 |
#If less then 500 trials
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04418297 | A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04418297 | Recruiting | Celltrion | 2020-12-31 |
| NCT03335332 | High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03335332 | Recruiting | University of Texas Southwestern Medical Center | 2020-06-30 |
| NCT03249272 | Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve | https://ClinicalTrials.gov/show/NCT03249272 | Completed | Duke University | 2019-03-31 |
| NCT03225001 | The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve | https://ClinicalTrials.gov/show/NCT03225001 | Active, not recruiting | Edwards Lifesciences | 2016-12-16 |
| NCT03178357 | “Cardiac Rehabilitation in Patients With Hypertrophic Cardiomyopathy”. | https://ClinicalTrials.gov/show/NCT03178357 | Recruiting | Institute of Cardiology, Warsaw, Poland | 2020-12-31 |
| NCT02842242 | A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction | https://ClinicalTrials.gov/show/NCT02842242 | Completed | MyoKardia, Inc. | 2017-11-30 |
| NCT02619825 | Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie) | https://ClinicalTrials.gov/show/NCT02619825 | Completed | French Cardiology Society | 2017-05-31 |
| NCT02590809 | Hypertrophic Cardiomyopathy Symptom Release by BX1514M | https://ClinicalTrials.gov/show/NCT02590809 | Completed | University Hospital, Bordeaux | 2016-07-06 |
| NCT02329184 | Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461 | https://ClinicalTrials.gov/show/NCT02329184 | Completed | MyoKardia, Inc. | 2016-03-31 |
| NCT02054221 | Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency. | https://ClinicalTrials.gov/show/NCT02054221 | Completed | Meshalkin Research Institute of Pathology of Circulation | 2015-05-31 |
| NCT01729702 | Neurohormonal Parameters in Hypertrophic Cardiomyopathies | https://ClinicalTrials.gov/show/NCT01729702 | Completed | French Cardiology Society | 2013-12-31 |
| NCT01721967 | Ranolazine for the Treatment of Chest Pain in HCM Patients | https://ClinicalTrials.gov/show/NCT01721967 | Completed | Duke University | 2015-11-30 |
| NCT01631006 | Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01631006 | Completed | University of Sao Paulo | 2012-12-31 |
| NCT01537926 | Hypertrophic Regression With N-Acetylcysteine in HCM | https://ClinicalTrials.gov/show/NCT01537926 | Completed | The University of Texas Health Science Center, Houston | 2016-12-31 |
| NCT01447654 | Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01447654 | Completed | Rigshospitalet, Denmark | 2014-06-30 |
| NCT01332162 | CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM | https://ClinicalTrials.gov/show/NCT01332162 | Recruiting | Hospital Clinic of Barcelona | 2019-12-31 |
| NCT04355260 | The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04355260 | Recruiting | Xijing Hospital | 2020-06-30 |
| NCT04222101 | Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04222101 | Recruiting | Le Bonheur Children’s Hospital | 2021-01-01 |
| NCT04164732 | Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04164732 | Recruiting | Novartis | 2022-02-22 |
| NCT04157205 | Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04157205 | Recruiting | Imperial College London | 2024-11-01 |
| NCT04141891 | Advancing Understanding of Transportation Options | https://ClinicalTrials.gov/show/NCT04141891 | Recruiting | University of Colorado, Denver | 2023-08-01 |
| NCT04133532 | Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04133532 | Recruiting | University Hospital, Motol | 2021-11-01 |
| NCT04066777 | The Effect of TASH in Patients With HOCM | https://ClinicalTrials.gov/show/NCT04066777 | Recruiting | Aarhus University Hospital Skejby | 2022-01-01 |
| NCT03953989 | Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03953989 | Recruiting | IRCCS San Raffaele | 2019-07-31 |
| NCT03906734 | Mitral Valve Management During Septal Myectomy | https://ClinicalTrials.gov/show/NCT03906734 | Completed | Meshalkin Research Institute of Pathology of Circulation | 2016-10-28 |
| NCT03877731 | Mitral Valve in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03877731 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2019-05-30 |
| NCT03832660 | Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03832660 | Recruiting | Newcastle University | 2021-11-30 |
| NCT03767855 | A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects | https://ClinicalTrials.gov/show/NCT03767855 | Completed | Cytokinetics | 2020-01-03 |
| NCT03723655 | A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM | https://ClinicalTrials.gov/show/NCT03723655 | Enrolling by invitation | MyoKardia, Inc. | 2022-06-30 |
| NCT03550573 | 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03550573 | Recruiting | Hospices Civils de Lyon | 2020-08-31 |
| NCT03537183 | Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? | https://ClinicalTrials.gov/show/NCT03537183 | Recruiting | Bispebjerg Hospital | 2021-09-01 |
| NCT03532802 | The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy. | https://ClinicalTrials.gov/show/NCT03532802 | Recruiting | Aarhus University Hospital Skejby | 2019-12-01 |
| NCT03496168 | Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER | https://ClinicalTrials.gov/show/NCT03496168 | Active, not recruiting | MyoKardia, Inc. | 2022-01-31 |
| NCT03470545 | Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03470545 | Completed | MyoKardia, Inc. | 2020-03-14 |
| NCT03450252 | Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03450252 | Recruiting | Barts & The London NHS Trust | 2021-02-28 |
| NCT03442764 | A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) | https://ClinicalTrials.gov/show/NCT03442764 | Completed | MyoKardia, Inc. | 2020-01-07 |
| NCT01150461 | Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01150461 | Completed | Massachusetts General Hospital | 2010-07-31 |
| NCT01127061 | Study of Exercise Training in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01127061 | Completed | University of Michigan | 2015-09-30 |
| NCT01081093 | Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement | https://ClinicalTrials.gov/show/NCT01081093 | Completed | Johann Wolfgang Goethe University Hospital | 2014-08-31 |
| NCT00821353 | Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00821353 | Completed | Institute of Cardiology, Warsaw, Poland | 2012-06-30 |
| NCT01614717 | Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY | https://ClinicalTrials.gov/show/NCT01614717 | Active, not recruiting | Abbott Medical Devices | 2020-09-30 |
| NCT03003299 | The PARTNER 3 - AVIV Trial | https://ClinicalTrials.gov/show/NCT03003299 | Recruiting | Edwards Lifesciences | 2021-12-31 |
| NCT02674958 | Mobilization of Endothelial Progenitor Cells and Aspirin | https://ClinicalTrials.gov/show/NCT02674958 | Recruiting | Ottawa Heart Institute Research Corporation | 2022-12-31 |
| NCT04219826 | REDWOOD-HCM: Randomized Evaluation of Dosing With CK-3773274 in Obstructive Outflow Disease in HCM | https://ClinicalTrials.gov/show/NCT04219826 | Recruiting | Cytokinetics | 2021-04-30 |
| NCT02560467 | Perfusion Imaging With Myocardial Contrast Echocardiography in HCM | https://ClinicalTrials.gov/show/NCT02560467 | Active, not recruiting | Oregon Health and Science University | 2019-09-01 |
| NCT01912534 | Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM | https://ClinicalTrials.gov/show/NCT01912534 | Active, not recruiting | HealthCore-NERI | 2019-07-31 |
| NCT01736566 | A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare | https://ClinicalTrials.gov/show/NCT01736566 | Active, not recruiting | Brigham and Women’s Hospital | 2016-11-04 |
| NCT00500552 | Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00500552 | Completed | University Hospital Birmingham | 2010-08-31 |
| NCT00319982 | Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem | https://ClinicalTrials.gov/show/NCT00319982 | Completed | Brigham and Women’s Hospital | 2012-12-31 |
| NCT00317967 | Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart | https://ClinicalTrials.gov/show/NCT00317967 | Completed | University of Calgary | 2010-10-31 |
| NCT00001965 | Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM) | https://ClinicalTrials.gov/show/NCT00001965 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00035386 | Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study | https://ClinicalTrials.gov/show/NCT00035386 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00011076 | Pirfenidone to Treat Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00011076 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001960 | Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle | https://ClinicalTrials.gov/show/NCT00001960 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001894 | A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00001894 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001631 | Study of Blood Flow in Heart Muscle | https://ClinicalTrials.gov/show/NCT00001631 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001396 | Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop… | https://ClinicalTrials.gov/show/NCT00001396 | Completed | National Institutes of Health Clinical Center (CC) | NA |
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04112511 | Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04112511 | Active, not recruiting | AHEPA University Hospital | 2020-12-31 |
| NCT03362164 | Evaluation of HEArt invoLvement in Patients With FABRY Disease | https://ClinicalTrials.gov/show/NCT03362164 | Recruiting | Wuerzburg University Hospital | 2032-03-31 |
| NCT03327623 | Sleep Apnea and Hypertrophic Cardiomyopathy (HCM) | https://ClinicalTrials.gov/show/NCT03327623 | Recruiting | Mayo Clinic | 2021-06-30 |
| NCT03271385 | Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease | https://ClinicalTrials.gov/show/NCT03271385 | Recruiting | RenJi Hospital | 2020-06-30 |
| NCT03092843 | Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM | https://ClinicalTrials.gov/show/NCT03092843 | Recruiting | The Cleveland Clinic | 2020-05-30 |
| NCT03076580 | An Integrative-“Omics” Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China | https://ClinicalTrials.gov/show/NCT03076580 | Recruiting | Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2018-07-01 |
| NCT03061994 | Metabolomic Study of All-age Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03061994 | Recruiting | Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2019-10-31 |
| NCT03043209 | Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy | https://ClinicalTrials.gov/show/NCT03043209 | Recruiting | The Cleveland Clinic | 2020-12-31 |
| NCT03040947 | MRI Sequence and Imaging Protocol Development | https://ClinicalTrials.gov/show/NCT03040947 | Recruiting | National Heart Centre Singapore | 2020-11-30 |
| NCT02922517 | Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT02922517 | Recruiting | Nantes University Hospital | 2017-12-31 |
| NCT02806479 | Hypertrophic Cardiomyopathy Pilot Study | https://ClinicalTrials.gov/show/NCT02806479 | Active, not recruiting | Oregon Health and Science University | 2020-06-30 |
| NCT02804269 | Molecular and Imaging Studies of Cardiovascular Health and Disease | https://ClinicalTrials.gov/show/NCT02804269 | Recruiting | National Heart Centre Singapore | 2033-07-31 |
| NCT02696135 | The Chinese Hypertrophic Cardiomyopathy Study(CHCS) | https://ClinicalTrials.gov/show/NCT02696135 | Recruiting | China National Center for Cardiovascular Diseases | 2025-12-31 |
| NCT01559714 | A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01559714 | Completed | Heartcenter, University Medical Center St. Radboud | 2019-05-01 |
| NCT00156429 | Genetic Predictors of Outcome in HCM Patients | https://ClinicalTrials.gov/show/NCT00156429 | Active, not recruiting | University of Pittsburgh | 2021-05-31 |
| NCT02432092 | Pediatric Cardiomyopathy Mutation Analysis | https://ClinicalTrials.gov/show/NCT02432092 | Recruiting | Indiana University | 2019-04-30 |
| NCT02417311 | Individualized Early Risk Assessment for Heart Diseases | https://ClinicalTrials.gov/show/NCT02417311 | Active, not recruiting | Universitätsklinikum Hamburg-Eppendorf | 2019-06-30 |
| NCT02234336 | Assessment of Wall Thickness in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT02234336 | Completed | Mayo Clinic | 2017-07-25 |
| NCT01873976 | Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers) | https://ClinicalTrials.gov/show/NCT01873976 | Active, not recruiting | Wayne State University | 2017-01-31 |
| NCT01873963 | Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) | https://ClinicalTrials.gov/show/NCT01873963 | Completed | Wayne State University | 2017-02-28 |
| NCT01623245 | Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01623245 | Completed | French Cardiology Society | 2014-12-31 |
| NCT04439942 | 4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04439942 | Recruiting | Centre Hospitalier Universitaire, Amiens | 2022-06-30 |
| NCT04402268 | Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04402268 | Completed | Poznan University of Medical Sciences | 2018-09-01 |
| NCT04112290 | A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT04112290 | Recruiting | Mayo Clinic | 2023-11-05 |
| NCT04080492 | Inherited and Non-inherited Cardiac Disease Quality of Life | https://ClinicalTrials.gov/show/NCT04080492 | Recruiting | The Cleveland Clinic | 2023-06-30 |
| NCT04056715 | Extended ECG Monitoring in HCM Patients | https://ClinicalTrials.gov/show/NCT04056715 | Recruiting | iRhythm Technologies, Inc. | 2022-01-01 |
| NCT04036799 | PRecIsion Medicine in CardiomyopathY | https://ClinicalTrials.gov/show/NCT04036799 | Active, not recruiting | The Hospital for Sick Children | 2020-12-31 |
| NCT03726424 | Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03726424 | Recruiting | Tongji Hospital | 2019-12-31 |
| NCT03572569 | Risk Stratification in Children and Adolescents With Primary Cardiomyopathy | https://ClinicalTrials.gov/show/NCT03572569 | Recruiting | German Heart Institute | 2020-12-31 |
| NCT01198899 | Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01198899 | Completed | University Hospital, Ghent | 2011-08-31 |
| NCT01160536 | The Perceived Impact of Children s Risk Status for Hypertrophic Cardiomyopathy on Families: an Exploratory Study | https://ClinicalTrials.gov/show/NCT01160536 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT01091480 | French Hypertrophic Cardiomyopathy Observatory | https://ClinicalTrials.gov/show/NCT01091480 | Recruiting | French Cardiology Society | 2023-12-31 |
| NCT02994615 | Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy | https://ClinicalTrials.gov/show/NCT02994615 | Recruiting | Lawson Health Research Institute | 2020-06-30 |
| NCT00753233 | Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00753233 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00692991 | Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures | https://ClinicalTrials.gov/show/NCT00692991 | Completed | Johns Hopkins University | 2016-01-31 |
| NCT00589836 | Assessment of Left Ventricular Torsion by Echocardiography Study | https://ClinicalTrials.gov/show/NCT00589836 | Completed | The Cleveland Clinic | 2008-04-30 |
| NCT00354328 | Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00354328 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00253682 | Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers | https://ClinicalTrials.gov/show/NCT00253682 | Completed | University of Miami | 2006-12-31 |
| NCT00074880 | The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00074880 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001881 | Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease | https://ClinicalTrials.gov/show/NCT00001881 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001871 | Study of Muscle Abnormalities in Patients With Specific Genetic Mutations | https://ClinicalTrials.gov/show/NCT00001871 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001530 | Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00001530 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001459 | Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers | https://ClinicalTrials.gov/show/NCT00001459 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00005251 | Genetic Analysis of Familial Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT00005251 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | NA |
| NCT00001878 | Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts | https://ClinicalTrials.gov/show/NCT00001878 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001746 | Screening for Inherited Heart Disease | https://ClinicalTrials.gov/show/NCT00001746 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001632 | Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease | https://ClinicalTrials.gov/show/NCT00001632 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001534 | Long Term Effects of Enalapril and Losartan on Genetic Heart Disease | https://ClinicalTrials.gov/show/NCT00001534 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00001225 | Family Studies of Inherited Heart Disease | https://ClinicalTrials.gov/show/NCT00001225 | Completed | National Institutes of Health Clinical Center (CC) | NA |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03049995 | Stress Echo 2020 - The International Stress Echo Study | https://ClinicalTrials.gov/show/NCT03049995 | Recruiting | Fatebenefratelli Hospital | 2020-12-31 |
| NCT02549664 | Exercise in Genetic Cardiovascular Conditions | https://ClinicalTrials.gov/show/NCT02549664 | Active, not recruiting | Yale University | 2021-12-30 |
| NCT02413450 | Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias | https://ClinicalTrials.gov/show/NCT02413450 | Enrolling by invitation | Johns Hopkins University | 2023-08-31 |
| NCT01915615 | HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01915615 | Active, not recruiting | University of Virginia | 2022-04-30 |
| NCT01792960 | Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy | https://ClinicalTrials.gov/show/NCT01792960 | Completed | Yonsei University | 2013-08-31 |
| NCT01334801 | Biomarkers in Aortic Stenosis - B.A.S.S. | https://ClinicalTrials.gov/show/NCT01334801 | Recruiting | Mayo Clinic | 2025-12-31 |
| NCT04189822 | Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank | https://ClinicalTrials.gov/show/NCT04189822 | Enrolling by invitation | University of British Columbia | 2025-12-31 |
| NCT03527342 | Sahlgrenska Cardiomyopathy Project | https://ClinicalTrials.gov/show/NCT03527342 | Enrolling by invitation | Göteborg University | 2028-01-31 |